Home
Conditions
Neuroblastoma

Clinical trial condition

Neuroblastoma

Explore clinical trials studying Neuroblastoma. Study availability and eligibility vary by location and protocol.

355 public trials 67 recruiting studies

Refine in advanced search Browse all conditions

Neuroblastoma trial results

Active, not recruiting

Methionine PET/CT Studies In Patients With Cancer

NCT00840047

Conditions: Brain Stem Glioma, Brain Tumors and/or Solid Tumors Including, Craniopharyngioma, +36 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, not recruiting

A Study of Avutometinib for People With Solid Tumor Cancers

NCT06104488

Conditions: Brain Diseases, Brain Neoplasms, CNS Tumor, Adult, +34 more
Locations: Children's Healthcare of Atlanta (Data Collection Only) Atlanta, Georgia, United States

Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States

View Trial Details

Active, not recruiting

Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk Neuroblastoma

NCT01192555

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, not recruiting

Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01

NCT02311621

Conditions: Ganglioneuroblastoma, Neoplasms, Neoplasms by Histologic Type, +8 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, not recruiting

DOTATOC PET/CT for Imaging NET Patients

NCT03583528

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +66 more
Locations: BC Cancer Vancouver, British Columbia, Canada

View Trial Details

Active, not recruiting

Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma

NCT02914405

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: University of Wisconsin Carbone Cancer Center; UW Hospital and Clinics; American Family Children's Hospital Madison, Wisconsin, United States

University Hospital Southampton NHS Foundation Trust Southampton, Hampshire, United Kingdom

University College London Hospital London, United Kingdom

View Trial Details

Active, not recruiting

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

NCT04483778

Conditions: Carcinoma, Clear Cell Sarcoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +66 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, not recruiting

Multi-modular Chimeric Antigen Receptor Targeting GD2 in Neuroblastoma

NCT05990751

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations: Great Ormond Street Hospital London, United Kingdom

View Trial Details

Active, not recruiting

iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma

NCT01953900

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +18 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Active, not recruiting

3rd Generation GD-2 Chimeric Antigen Receptor and iCaspase Suicide Safety Switch, Neuroblastoma, GRAIN

NCT01822652

Conditions: Disease Attributes, Neoplasms, Neoplasms by Histologic Type, +11 more
Locations: Houston Methodist Hospital Houston, Texas, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Neuroblastoma

Neuroblastoma trial results

Related conditions